Efficacy of 100 mg of double-bolus alteplase in achieving complete perfusion in the treatment of acute myocardial infarction
- 31 January 1994
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 23 (1) , 6-10
- https://doi.org/10.1016/0735-1097(94)90495-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarctionJournal of the American College of Cardiology, 1992
- Effectiveness and safety of a single intravenous Bolus injection of tissue-type plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1992
- Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 studyJournal of the American College of Cardiology, 1992
- Effectiveness of double bolus alteplase in the treatment of acute myocardial infarctionThe American Journal of Cardiology, 1991
- A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction.Heart, 1991
- Effectiveness of multiple bolus administration of tissue-type plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1990
- Enhancing thrombolytic efficacy by means of “front-loaded” administration of tissue plasminogen activatorJournal of the American College of Cardiology, 1989
- Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1989
- Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1989
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985